According to experts at the IAS 2025 meeting in Kigali, Rwanda, AI revolutionizes HIV vaccine development by enhancing design ...

Humanity, according to Michael Zey, a noted sociologist, has the wherewithal to controlling its own destiny, owing to ...

Calls to ban Donald Trump from Scotland are short-sighted, says reader Whether or not we like it, Donald Trump is the elected ...

As HIV cases continue to rise in the Philippines, especially among the youth, a new global development may offer hope in ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...

ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

WHO director general Tedros Adhanom Ghebreyesus says this new drug—which only needs to be injected twice a year—is the next ...

As summer kicks into full gear and people are spending more time outside, there's one thing on many people's minds—ticks.

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection.

Global health leaders and advocates challenged attendees of IAS to support the work of the partnerships that are creating patient-focused innovations for HIV prevention and treatment.

During his 36-year career at Cancer Center, Michael Emerman, PhD, made fundamental discoveries about HIV, the retrovirus that ...